The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


LG-octaplas, Powder and solvent for solution for infusion



Octapharma (IP) SPRLPA2219/002/002

Main Information

Trade NameLG-octaplas, Powder and solvent for solution for infusion
Active SubstancesHuman plasma protein
Dosage FormPowder and solvent for solution for infusion
Licence HolderOctapharma (IP) SPRL
Licence NumberPA2219/002/002

Group Information

ATC CodeB05AA Blood substitutes and plasma protein fractions

Status

License statusAuthorised
Licence Issued10/03/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back